Pages that link to "Q37802152"
The following pages link to Targeting the heparin-binding epidermal growth factor-like growth factor in ovarian cancer therapy (Q37802152):
Displaying 14 items.
- Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis (Q26851836) (← links)
- Ovarian cancer cell heparan sulfate 6-O-sulfotransferases regulate an angiogenic program induced by heparin-binding epidermal growth factor (EGF)-like growth factor/EGF receptor signaling (Q33675726) (← links)
- Intra- and postoperative catumaxomab in patients with epithelial ovarian cancer: safety and two-year efficacy results from a multicentre, single-arm, phase II study (Q34354529) (← links)
- A recombinant decoy comprising EGFR and ErbB-4 inhibits tumor growth and metastasis (Q35791377) (← links)
- Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways (Q35837949) (← links)
- High-grade serous ovarian cancer cell lines exhibit heterogeneous responses to growth factor stimulation (Q36354166) (← links)
- Targeting hepatic heparin-binding EGF-like growth factor (HB-EGF) induces anti-hyperlipidemia leading to reduction of angiotensin II-induced aneurysm development (Q38287552) (← links)
- Cross-reacting material 197 reverses the resistance to paclitaxel in paclitaxel-resistant human ovarian cancer (Q38819410) (← links)
- Heparin-binding epidermal growth factor-like growth factor is a potent regulator of invasion activity in oral squamous cell carcinoma (Q39419452) (← links)
- Sweet bing cherries lower circulating concentrations of markers for chronic inflammatory diseases in healthy humans. (Q51345838) (← links)
- Discovery of HB-EGF binding peptides and their functional characterization in ovarian cancer cell lines (Q64054556) (← links)
- Role of Heparin-Binding Epidermal Growth Factor-Like Growth Factor in Oxidative Stress-Associated Metabolic Diseases (Q89799077) (← links)
- circCELSR1 (hsa_circ_0063809) Contributes to Paclitaxel Resistance of Ovarian Cancer Cells by Regulating FOXR2 Expression via miR-1252 (Q92692735) (← links)
- CRM197 reverses paclitaxel resistance by inhibiting the NAC-1/Gadd45 pathway in paclitaxel-resistant ovarian cancer cells (Q93141631) (← links)